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former are on the kidney transplant waiting list, due to match criteria, severity of disease and regional policies. 6, 7 In 2001, nearly 70% of Caucasian patients on the list received a transplant within 5 years, whereas only 54% of African-Americans received a transplant over the same time period. 5 Even after receiving renal transplants, African-American patients fare substantially worse long term than Caucasians or other minorities. Survival rates in African-Americans drop more progressively (90% at 1 year, 73% at 3 years and 59% at 5 years) compared with Caucasians (92%, 84% and 76%, respectively). 8, 9 Similarly, while the overall rate of graft survival from both deceased and living donor renal transplants has improved in the past decade by approximately 13% and 7%, respectively, African-Americans continue to have worse graft function and shorter graft survival than Caucasians. [10] [11] [12] Studies have suggested multiple factors --comorbid conditions, higher immunological risks and other biological and socioeconomic factors --may contribute to disparities in kidney transplant outcomes. 13, 14 For example, worse outcomes for African-American transplant recipients have been attributed to poor education, socioeconomic status, cultural influences, lack of continuous care, etc. [15] [16] [17] In a study of transplant recipients within the Veterans Affairs health system, where access to care is equivalent for all patients, large racial disparities in kidney transplant outcomes were still observed. 18 Even when access to medications was essentially guaranteed, poorer outcomes in African-Americans versus Caucasians were documented, with more rejection and allograft failure despite comparable immunosuppression. 19 In 2006, Goldfarb-Rumyantev et al. showed significantly better outcomes for patients who had private insurance than those with Medicare. 20 Other studies have shown that an adjustment for a number of demographic factors (e.g. socioeconomic or insurance status) could not fully explain the differences observed between racial/ethnic groups 21 and that race/ ethnicity remains a significant factor affecting graft survival. 22 As both physiological and environmental factors contribute significantly to disparities in outcomes, understanding and dissecting the determinants that unfairly distribute the burden of disease in kidney transplant recipients is critical to ensure equitable transplant access and outcomes. The purpose of this study is to identify the risk factors that can adversely affect kidney transplant outcomes in a single transplant center, and specifically highlight areas suited for targeted interventions that would improve outcomes across four racial/ethnic groups defined as African-American, Caucasian, Hispanic and Other.
METHODS
Retrospective chart review of all adult kidney transplant recipients at a single hospital in our health system from January 1, 1999, to December 31, 2013, was approved by the Institutional Review Board. Initially, 381 primary kidney transplants were identified through the Organ Procurement and Transplantation Network. Patients with a history of multiple organ transplantation, prior renal transplantation or those who died within 30 days after transplantation were excluded, as were duplicated patient entries. One patient with 23 years of dialysis was excluded as an outlier. A total of 307 unique patients comprised the study sample ( Figure 1 ).
Self-reported race/ethnicity registries were subdivided into Caucasian, African-American, Hispanic and Other (Asians, Pacific Islanders, Native Americans, Alaskan Natives, etc.). Body mass index (BMI) was calculated using height and weight at the time of procedure, and also at 0-3 years, 3-5 years and 5-10 years after procedure (if information was available). Date of birth was collected and used to calculate recipient age at time of transplant. Comorbidities, including history of hypertension, diabetes, hyperlipidemia, myocardial infarction, heart failure, cerebrovascular accident and coronary artery disease prior to transplantation, were Clinical data for time on dialysis, length of hospital stay, blood urea nitrogen (BUN) level, glomerular filtration rate and creatinine level were recorded at baseline, time of discharge and 1 week, 30 days, 3 months, 1 year and 3 years posttransplant.
The primary outcome for this study was patient survival as determined by all-cause mortality. The secondary outcome was graft survival, and the return of a patient to hemodialysis or peritoneal dialysis on a permanent basis was recorded as graft loss. The association of race with patient and graft survival in the overall cohort was examined among the four groups.
Statistical Analysis
All categorical variables were summarized using frequency and percentage. Percentages were compared across the four racial/ethnic groups using chi-square or Fisher's exact test. Data are summarized as mean ± standard deviation for continuous variables, and Analysis of Variance (ANOVA) was used to compare means across the four groups. Additional multiple comparison tests were used to compare paired groups. Cumulative probabilities for patient and graft survival were estimated using Kaplan-Meier survival function. Patient and graft survival rates were compared across the four groups using log-rank test. Mean patient and graft survival years also were calculated for all races. The Cox proportional hazards model was used to determine the risk factors for patients as well as for graft survival. For all statistical tests, significance was set at P<0.05. All statistical analyses were performed using SAS 9.4 (SAS Institute Inc., Cary, NC).
RESULTS

Patient Characteristics
The most prominent causes of end-stage renal disease, as collected from United Network for Organ Sharing, were diabetic nephropathy (type I and type II), hypertensive nephrosclerosis and polycystic kidney disease ( Figure 2 ). Diabetic nephropathy and hypertensive nephrosclerosis contributed to almost half the end-stage renal disease population (45%).
Demographics and baseline characteristics of the patient population are summarized by race in Table 1 . The study cohort was evenly distributed between age groups, was 58% male and was 61% Caucasian. The majority of donors were Caucasian (76%) as well as cytomegalovirus (CMV)-negative (52%) and hepatitis C (HepC)-negative (98%). Most patients suffered from hypertension (93%), hyperlipidemia (72%) and diabetes (56%). Patient proportions were different across the four races for the following variables: donor race, donor CMV status, recipient CMV status, recipient HepC status, delayed graft function, BMI, alcohol and other drug abuse, pretransplant diabetes and 1-year posttransplant diabetes. Specifically, there was a higher proportion of Caucasian donors than any other group, alcohol/drug abuse history was higher in Caucasians (42%), African-Americans (49%) and Hispanics (25%) compared with Other (12%), and African-Americans and Caucasians, and Other had a lower proportion of diabetics compared with the rest of the groups. In the time period immediately following transplantation (0-1 years), the proportion of Hispanics with diabetes was higher than African-Americans, Caucasians or Other. 
Relationship Between Patient Race and Patient or Graft Survival
Patient survival probability after transplantation was similar for patients across the four groups ( Figure 3A) . At 1, 3 and 5 years posttransplant, patient survival rates by race also were similar (Table 3A ). The mean patient survival time was slightly higher in Caucasians (4.23 years) compared with African-Americans (3.43 years), Hispanics (3.75 years) and Other (2.65 years), but this was not statistically significant (Table 3C ).
Graft survival probability was higher in Caucasians compared with African-Americans and Other ( Figure  3B , P<0.05 for Caucasian vs. African-American and Caucasian vs. Other). Although graft survival was similar between the two races at 1 and 3 years posttransplant (Table 3B) 
Factors Impacting Patient and Graft Survival
All factors that were associated with patient death by univariate analysis are presented in Table 4 , which shows that patient survival was multifactorial and depended on a variety of patient factors such as age, type of transplant (cadaveric vs. living), serum creatinine and BUN levels, and comorbidities such as diabetes, coronary artery disease, myocardial infarction and heart failure. Cox regression modeling for multivariate analysis indicated that preprocedure heart failure, graft loss, HepC-positive donor status and high 30-day BUN were significant risk factors for patient survival. The hazard ratio (HR) for each one of these factors is shown in Figure 4 . Most notably, heart failure conferred a threefold risk, graft loss a 3.35-fold risk and HepC-positive donor a sevenfold risk for early patient death.
For the secondary outcome of graft survival, univariate analysis showed that graft survival also was multifactorial (Table 4 ). Multivariate analysis indicated that female gender (HR: 2.77), HepCpositive donor status (HR: 10.95), smoking history (HR: 2.82), preprocedure myocardial infarction (HR: 4.2), cerebrovascular accident at 1-3 years (HR: 7.41) and 1-year elevated serum creatinine (HR: 4.76) were independent risk factors for graft loss.
DISCUSSION
In examining the factors affecting patient and graft survival following kidney transplantation across Caucasians, African-Americans, Hispanics and other races, we found that patient survival rates were similar at 1, 3 and 5 years posttransplantation. However, African-Americans and Other had significantly lower graft survival at 5 years posttransplant compared with Caucasians and Hispanics. On average, the time to patient death was shorter in African-Americans and Other compared with Caucasians and the time to graft loss also was shorter in African-Americans compared with the rest of the groups, though these differences were not found to be statistically significant. In the end both patient death and graft loss were multifactorial, and no single factor stood out as being independently associated with either outcome. Female gender, HepCpositive donor, smoking history, myocardial infarction and cerebrovascular accident all were associated with graft loss.
Overall patient outcomes in our study were comparable to national averages for patient and graft survival, and our 5-year graft survival rate was 15% higher than data from the National Institutes of Health published in 2012. 23 However, despite the overall success of kidney transplants, African-Americans and patients in the Other racial/ethnic group had poorer graft outcomes 5 years after transplantation compared with Caucasian patients. Even though overall access to health care and availability of immunosuppressants have improved nationally, racial disparity in graft survival still exists as shown in past studies. 24, 25 Racial differences in genotypes or gene expressions like angiotensin receptors, transforming growth factor-β, etc. 26, 27 and socioeconomic factors such as decreased access to health care and lower income status adversely affect transplant outcomes in African-Americans. 28 In this regard, our study showed that African-Americans had a significantly longer time on dialysis compared with Caucasians, which could be related to limited access to transplants in African-Americans due to greater delays in referral to transplant centers and longer waiting times for transplants. Interestingly, our data also showed that while only 6.6% of Caucasians had more than 5 years of dialysis, all other groups were higher, with African-Americans at 17%, Hispanics at 9.5% and Other at 31.3% of their respective populations. While the high proportion of Other with high dialysis times could be explained by immunologic factors and availability of histocompatibility matches, the high dialysis times in African-Americans and Hispanics are more likely related to poor access to transplants. Recently a community-based participatory research trial called RADIANT was launched with the purpose of reducing disparities in access to kidney transplantation in the states of Georgia, North Carolina and South Carolina. 29 The results of this trial will inform future educational interventions and studies to monitor access to transplantation in our center.
Although we did not study immunologic factors contributing to worse graft survival in African-Americans, we did find nonimmunologic differences such as a greater proportion of African-Americans and Hispanics with higher creatinine and BUN levels pretransplant, at discharge and at 1 week posttransplant. The poor pretransplant kidney functional status seen in African-Americans also was likely related to the higher incidence of pretransplant diabetes compared with Caucasians. Although our analysis did not indicate a clear relationship between these factors and patient/graft survival, it is likely that the presence of higher comorbidities in African-Americans results in worse outcomes.
Overall, patient and graft survival was dependent on several factors and no one variable could be singled out as contributing to poorer outcomes in transplant recipients across the different races. Female gender was associated with graft loss, which could be related to increased female-male donations compared with male-female donations. 30 Designing studies to take into account the gender of donors and recipients might be an important consideration in the future. Our study showed that certain comorbidities, such as presence of preprocedure heart failure, were associated with patient death (HR: 3.02), and preprocedure myocardial infarction and cerebrovascular accident at 1-3 years postprocedure both contributed to poor graft outcomes (HR: 4.2 and 7.41, respectively). While these comorbidities were distributed more or less equally across racial/ethnic groups, all are modifiable and can be linked to lifestyle and behavior. For example, smoking history was associated with graft loss (HR 2.82), and this behavior is modifiable.
Study Limitations
The overall sample size of our population cohort did not allow for comparison when subdivided into individual races. Although African-Americans were well-represented proportionately (19%), the total number was small (59 patients). Also, we were unable to obtain all necessary follow-up data, as not all patients stayed within our institution's health system after transplantation or were lost to followup. Finally, there were a number of variables for which more than 20% of electronic health record information was missing, limiting the analysis and interpretation of results.
CONCLUSIONS
Our study showed that disparities exist in graft outcomes across different racial/ethnic groups within a single center, despite overall kidney transplant success rates on par with national averages. The causes of graft loss are multifactorial. Prospective interventional studies with strategies to improve graft function and survival rates for kidney transplantation in African-Americans and other minorities are warranted.
Patient-Friendly Recap
• The best treatment for patients with serious renal disease is kidney transplantation.
• Success rates of these transplants vary among different races and ethnicities.
• The authors analyzed a series of patient and disease factors to identify possible contributors to population disparities.
• They found that African-American patients had more time on dialysis, higher pretransplant creatinine levels and higher BMI compared to Caucasian patients, all of which may contribute to their higher rate of graft failure.
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